Research Article| Volume 32, ISSUE 3, 106988, March 2023

Immediate implantable loop recorder implantation for detecting atrial fibrillation in cryptogenic stroke



      Atrial fibrillation (AF) is suspected as the main cause of stroke in the majority of patients presenting with cryptogenic stroke (CS). Implantable loop recorders (ILR's) are indicated for detecting AF in these patients.
      The short term (<1 month) and long-term AF detection rates in patients inserted with an ILR immediately after CS is reported. Secondly, we compare the safety of nurse led vs physician led ILR implantation in these patients.


      This is a retrospective review of all patients who underwent inpatient ILR implantation (Medtronic Linq) between May 2020 and May 2022 at East Sussex Healthcare NHS trust. All patients were remotely monitored via the FOCUSONTM monitoring and triage service.


      A total of 186 subjects were included in the study and were followed up for a mean period of 363.0 +/− 222.6 days. The mean time between stroke and ILR was 7.0 +/− 5.5 days. The mean time between referral and ILR was 1.0 +/− 2.0 days. AF was detected in 25 (13.4%) patients. During the first 30 days of monitoring, AF was detected in 9 (4.8%) patients.
      The number of ILR implants performed by the specialist nurse was 107 (57.5%). There was no significant difference in the major complication rate (requiring device removal) between nurse and physician led implant (1 (0.95%) vs 0 (0%), p value = 0.389).


      Inpatient ILR for cryptogenic stroke is feasible. The rate of AF detection in the first month post CS is 4.8% however, more AF was detected up to one year post implant, suggesting rationale for proceeding directly to ILR implant in these patients before discharge to not delay treatment. A nurse led service is also viable with no significant difference in the major complication rate compared to physician led implants.



      ILR (implantable loop recorder), AF (atrial fibrillation), CS (cryptogenic stroke)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • SSNAP
        RC of PSSNAP. How good is stroke care?.
        First SSNAP Annual Report Report Prepared on Behalf of the Intercollegiate Stroke Working Party December 2014. SSNAP, 2014
        • Yaghi S.
        • Bernstein R.A.
        • Passman R.
        • Okin P.M.
        • Furie KL.
        Cryptogenic stroke: research and practice.
        Circ Res. 2017; 120: 527-540
        • Kannel W.B.
        • Abbott R.D.
        • Savage D.D.
        • Mcnamara PM.
        Epidemiologic features of chronic atrial fibrillation: the framingham study.
        N Engl J Med. 1982; 306: 1018-1022
        • Oppenheimer S.
        Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance stephen oppenheimer.
        Clin Auton Res. 2006; 16: 6-11
        • Sanna T.
        • Diener H.C.
        • Passman R.S.
        • Di Lazzaro V.
        • Bernstein R.A.
        • Morillo C.A.
        • et al.
        Cryptogenic stroke and underlying atrial fibrillation.
        N Engl J Med. 2014; 370: 2478-2486
        • Buck B.H.
        • Hill M.D.
        • Quinn F.R.
        • Butcher K.S.
        • Menon B.K.
        • Gulamhusein S.
        • et al.
        Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the per diem randomized clinical trial.
        JAMA J Am Med Assoc. 2021; 325 (Jun): 2160-2168
        • Lim W.Y.
        • Papageorgiou N.
        • Sukumar S.M.
        • Alexiou S.
        • Srinivasan N.T.
        • Monkhouse C.
        • et al.
        A nurse-led implantable loop recorder service is safe and cost effective.
        J Cardiovasc Electrophysiol. 2019; 30 (Dec): 2900-2906
        • Sanders P.
        • Pürerfellner H.
        • Pokushalov E.
        • Sarkar S.
        • Di Bacco M.
        • Maus B.
        • et al.
        Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the reveal LINQ usability Study.
        Heart Rhythm. 2016; 13 (Jul): 1425-1430
        • Asaithambi G.
        • Monita J.E.
        • Annamalai M.R.
        • Ho B.M.
        • Marino E.H.
        • Hanson SK.
        Prevalence of atrial fibrillation with insertable cardiac monitors in cryptogenic stroke: a single-center experience.
        J Electrocardiol. 2018; 51 (Nov): 973-976
        • Milstein N.S.
        • Musat D.L.
        • Allred J.
        • Seiler A.
        • Pimienta J.
        • Oliveros S.
        • et al.
        Detection of atrial fibrillation using an implantable loop recorder following cryptogenic stroke: implications for post-stroke electrocardiographic monitoring.
        J Interv Card Electrophysiol. 2020; 57 (Jan): 141-147
        • Ahluwalia N.
        • Graham A.
        • Honarbakhsh S.
        • Tarkas T.
        • Martin S.
        • Monkhouse C.
        • et al.
        Contemporary practice and optimising referral pathways for implantable cardiac monitoring for atrial fibrillation after cryptogenic stroke.
        J Stroke Cerebrovasc Dis. 2022; 31 (Jul)106474
        • De Angelis M.V.
        • Di Stefano V.
        • Franciotti R.
        • Furia N.
        • Di Girolamo E.
        • Onofrj M.
        • et al.
        Cryptogenic stroke and atrial fibrillation in a real-world population: the role of insertable cardiac monitors.
        Sci Rep. 2020; 10 (Dec): 1-6
      1. 13. The National Institute for Health and Care Excellence (NICE) (2020) Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke.( NICE guidance DG41). Available from:[Accessed 1st Decemeber 2022]

        • Mahase E.
        NICE recommends implantable monitor to identify atrial fibrillation after stroke.
        BMJ. 2020; 368: m133
        • Diamantopoulos A.
        • Sawyer L.M.
        • Lip G.Y.H.
        • Witte K.K.
        • Reynolds M.R.
        • Fauchier L.
        • et al.
        Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.
        Int J Stroke. 2016; 11: 302-312
      2. Patel A., Berdunov V., King D., Quayyum Z., Wittenberg R., Knapp M. Current, future and avoidable costs of stroke in the UK [Internet]. Available from:[Accessed 1st Decemeber 2022]

      3. Desai AD, Howe E, Coromilas E, Zhang Y, Dizon JM, Willey J, et al. Predictors of atrial fibrillation on implantable cardiac monitoring for cryptogenic stroke. J Interv Card Electrophysiol. 2022 Oct 1;65(1):7–14. 

        • Wechselberger S.
        • Kronborg M.
        • Huo Y.
        • Piorkowski J.
        • Neudeck S.
        • Päßler E.
        • et al.
        Continuous monitoring after atrial fibrillation ablation: the LINQ AF study. Eur Eur pacing arrhythm card electrophysiol J Work Groups card pacing arrhythm card.
        Cell Electrophysiol Eur Soc Cardiol. 2018; 20: f312-f320
        • Kamel H.
        • Hunter M.
        • Moon Y.P.
        • Yaghi S.
        • Cheung K.
        • Di Tullio M.R.
        • et al.
        Electrocardiographic left atrial abnormality and risk of stroke: northern Manhattan study.
        Stroke. 2015; 46 (Nov): 3208-3212
        • Benjamin E.J.
        • D'Agostino R.B.
        • Belanger A.J.
        • Wolf P.A.
        • Levy D.
        Left atrial size and the risk of stroke and death. the Framingham heart study.
        Circulation. 1995; 92 (Aug 15): 835-841
        • Kamel H.
        • Longstreth W.T.
        • Tirschwell D.L.
        • Kronmal R.A.
        • Broderick J.P.
        • Palesch Y.Y.
        • et al.
        The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke (ARCADIA) randomized trial: rationale and methods.
        Int J Stroke Off J Int Stroke Soc. 2019; 14 (Feb): 207-214